BOPA 2022 | Considerations for researching pharmacological management of pediatric cancer

Vanessa McLelland, MPharm, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK, discusses the effects of international collaboration on a recent trial for the pharmacological management of pediatric cancer. This interview took place at the British Oncology Pharmacy Association (BOPA) 2022 Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.